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FEED CAN ACCOUNT FOR UP TO 80% of the production costs involved in beef cattle production (28, 53) . Compensatory growth is a phenomenon commonly exploited by producers to reduce the overwintering feed costs of beef cattle (35) . It may be defined as a physiological process whereby an animal has the potential, following a period of restricted feed intake, to undergo accelerated growth upon re-alimentation (31) . Previous investigations into the underlying biology of compensatory growth by our own group and by others have suggested greater feed intake and efficiency, reduced metabolic rate, and alterations in energy partitioning and tissue deposition to all be associated with the accelerated growth phenomenon (31, 37, 62, 64, 77, 78) . However, despite its potential importance to reducing the costs of beef cattle production systems, there is a dearth of knowledge in relation to the biological and in particular the molecular mechanisms regulating the compensatory growth phenomenon.
The somatotropic axis is an evolutionarily conserved signaling pathway involved in a number of fundamental biological processes, including cellular growth, proliferation, differentiation, and the maintenance of homeostasis in animals (17, 23) . During dietary restriction, signaling within the somatotropic axis becomes refractory or uncoupled such that although growth hormone concentrations typically increase, this is not mirrored in greater hepatic synthesis of IGF-1 (11) . Studies, including our own (37) and those of Yambayamba et al. (77) and Hornick et al. (31) have identified lower circulating IGF-1 concentrations in animals fed a restricted diet compared with control animals. However, during subsequent re-alimentation and compensatory growth, systemic IGF-1 concentrations tended to increase as re-alimentation continued. Furthermore, the liver, which is the primary site of systemic IGF-1 production (58) , is typically one of the most physically responsive tissues during dietary restriction. It also tends to display rapid compensatory growth upon re-alimentation (36, 63, 77) .
However, despite clear evidence for uncoupling and subsequent recoupling of the somatotropic axis in response to periods of both feed restriction and re-alimentation it is not known what is controlling these effects. Furthermore, there is a dearth of published information on the molecular control of the somatotropic axis during the exaggerated body growth typically observed throughout re-alimentation. Therefore, the aim of this study was to examine the effect of restricted feeding and subsequent re-alimentation on: 1) pituitary gland sensitivity to synthesize growth hormone, the precursor to IGF-1 through utilization of a growth hormone releasing hormone (GHRH) challenge and 2) hepatic transcript abundance of component genes of the somatotropic axis. During compensatory growth our study focused on the first 55 days of realimentation where typically the greatest increment of growth is achieved (31) .
MATERIALS AND METHODS
All procedures involving animals were approved by the University College Dublin Animal Research Ethics Committee and licensed by the Irish Department of Health and Children, in accordance with the European Community Directive 86/609/EC.
Animal Model
The experiments reported in this study were conducted in association with a larger study designed to examine the physiological control of restricted growth and subsequent re-alimentation in cattle (36) . In brief, 60 Holstein Friesian bulls with a mean (SE) age of 479 (15) days and body weight 370 (35) kg were blocked according to weight, age, sire, and a pretrial live weight gain, into one of two groups: 1) a restricted feed allowance for 125 days (RES, n ϭ 30) followed by ad libitum access to feed for 55 days or 2) ad libitum access to feed throughout (ADLIB, n ϭ 30). The first 125 days was denoted as period 1, and the subsequent 55 days as period 2. All animals were offered a total mixed ration diet consisting of 70% concentrate and 30% grass silage on a dry matter basis (36) . Diets were fed individually using Calan gates (American Calan, Northwood, NH), with the proportion of feed required based on each animal's own individual body weight (53) . Animals were weighed on 2 consecutive days at the start of the study, then at the end of period 1 and again at the end of period 2. Additionally, throughout the study, animals were weighed every 2 wk during period 1 and weekly during period 2. Weighing was conducted at the same time each morning before fresh feed was offered. During period 1, RES animals were managed so as to achieve a target mean daily growth rate of 0.6 kg/day. At the end of period 1, 15 animals from each treatment were slaughtered. All remaining animals were slaughtered at the end of period 2.
Experiment 1
Growth hormone releasing hormone challenge. From the original group of 60 bulls, 24 animals were selected randomly (RES, n ϭ 12; ADLIB, n ϭ 12) and retained for use in this experiment over both periods 1 and 2. On days 89 and 35 of periods 1 and 2, respectively, a growth hormone releasing hormone (GHRH) challenge was performed on the 24 animals selected. To facilitate intensive blood sampling, indwelling jugular catheters were fitted aseptically, to each bull on the day preceding each challenge. Catheters were placed in the right jugular vein via a 12-gauge spinal needle and vinyl tubing. All catheters were exteriorized on the neck of the animal, filled with sterile 3.8% sodium citrate solution and plugged with a stopper. Catheters were secured in place in resealable pouches attached to the animal's hide with the aid of an adhesive cement, Velcro, and zinc oxide wrapping bandages. Feed was withdrawn from all animals 12 h prior to GHRH infusion. Animals had access to water at all times. All animals were infused with a 0.0005% GHRH solution in sterile 0.9% saline, at a rate of 20 g bovine GHRH (Bachem, Essex, UK) per 100 kg body wt (69) . The GHRH solution was administered via the right catheter, and blood was sampled from the same catheter. Following administration of the GHRH solution, the catheters were immediately flushed with 10 ml sterile 3.8% saline. Blood samples were collected into evacuated lithium heparin coated tubes (Vacuette tubes; Cruinn diagnostics, Dublin, Ireland) at 15, 5, and 0 min prior to and at 5, 10, 15, 20, 30, 45, 60, 75, 90, 105 , and 120 min post-GHRH infusion and were centrifuged at 1,500 g for 15 min at 4°C. The plasma was decanted and subsequently stored at Ϫ20°C pending analysis.
Blood analytes. Blood samples collected at each of the 14 bleeds from each animal were subsequently assayed for concentrations of both IGF-1 and growth hormone. IGF-I concentrations in blood plasma were determined by radioimmunoassay after an acid-ethanol extraction and Tris neutralization procedure, as described by Spicer et al. (68) . The intra-assay coefficient of variability (CV) for IGF-1 quantification was 12.96, 6.6, and 9.6% for low, medium, and high standards, respectively while the interassay CV was 14.44, 10.89 and 17.34% for low, medium and high standards, respectively. Plasma samples were assayed for growth hormone using a bovine growth hormone ELISA kit (Cusabio Biotech, Wuhan, China). The intraassay CV for growth hormone was 5.9% and the interassay CV 7.6%.
Experiment 2.
Tissue collection, RNA extraction, and purification. At the end of each period, 15 RES and 15 ADLIB animals were slaughtered. On each day of slaughter, animals were transported from Grange Beef Research Centre and transported to a commercial abattoir in the morning. Animals did not receive fresh feed on the morning of slaughter but did have access to their allocated feed from the previous morning. At slaughter, hepatic tissue was collected from all animals. All surgical instruments used for tissue collection were sterilized and treated with RNA Zap (Ambion, Applera Ireland, Dublin, Ireland) prior to use. Samples were washed with sterile DPBS and immediately snap-frozen in liquid nitrogen and subsequently stored at Ϫ80°C. Total RNA was isolated from liver tissue using the Qiagen Rneasy mini kit (Qiagen). The quantity of the RNA isolated was determined by measuring the absorbance at 260 nm using a Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE). RNA quality was assessed on the Agilent Bioanalyser 2100 using the RNA 6000 Nano Lab Chip kit (Agilent Technologies Ireland, Dublin, Ireland). RNA samples with an absorbance (A260/280) of between 1.8 and 2, with 28S/18S ratios ranging from 1.8 to 2.0 and with an RNA integrity number of between 8 and 10 were deemed to be of high quality.
Complementary DNA synthesis. Total RNA (2 g) was reverse transcribed into cDNA using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) using Multiscribe reverse transcriptase according to manufacturer's instructions. Samples were stored at Ϫ20°C pending further analysis.
Primer design and reference gene selection. All primers targeting reference and candidate genes were obtained from a commercial supplier (Sigma-Aldrich Ireland, Dublin, Ireland). Details of primer sets used in this study are listed in Table 1 . All amplified PCR products were sequenced to verify their identity (Macrogen Europe, Amsterdam, The Netherlands).
Gene-specific primers used in this study were previously employed in a study by Cummins et al. (21) or were specifically designed for use in the current study. Primer3 (http://frodo.wi.mit.edu/primer3/) and Primer BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) software were utilized to design primers (39, 73) . Primer specificity was established using the Basic Local Alignment Search Tool (BLAST) from the National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST/).
To determine the relative gene expression levels, suitably highly stable reference genes were required. In the current study, five reference genes were tested across all samples with qRT-PCR including ␤-actin (ACTB), ribosomal protein S9 (RPS9), adenylate cyclaseassociated protein 1 (CAP1), serine/arginine repetitive matrix 2 (SRRM2), and 26S proteasome non-ATPase regulatory subunit 2 (PSMD2). These genes have previously been used as reference genes in the literature (21) . Data were analyzed using GeNorm (GenEx 5.2.1.3; MultiD Analyses, Gothenburg, Sweden). GeNorm is a modelbased approach software that measures the overall stability of the tested reference genes by calculating the intra-and intergroup CV and combining both coefficients to give a stability value (M value). A lower M value implies a higher stability in gene expression across all samples. An M value of 1.5 is specified as the default minimum coefficient by the GeNorm program. In the current study, M value scores were 0.82, 0.82, 1.32, 1.63, and 1.74 for ACTB, CAP1, RPS9, PSMD2 and SRRM2 respectively. On this basis, ACTB, CAP1, and RPS9 were selected as suitably stable reference genes.
Quantitative real-time PCR. Following reverse transcription, cDNA quantity was determined and standardized to the required concentration for quantitative (q)PCR. Triplicate 20 l reactions were carried out in 96-well optical reaction plates (Applied Biosystems, Warrington, UK), containing 2 l cDNA, 10 l Fast SYBR Green PCR Master Mix (Applied Biosystems), 7 l nuclease-free H2O, and 1 l forward and reverse primers (250 -1,000 nM per primer). Assays were performed using the ABI 7500 Fast qPCR System (Applied Biosystems) with the following cycling parameters; 95°C for 20 s and 40 cycles of 95°C for 3 s, 60°C for 30 s followed by amplicon dissociation (95°C for 15 s, 60°C for 1 min, 95°C for 15 s, and 60°C for 15 s). Optimal cDNA concentration, primer efficiencies, and concentrations were determined. To minimize variation, all samples included in each analysis were derived from the same cDNA batch, prepared under the same conditions, and samples were run in triplicate. The specificity of the reaction products was also confirmed by dissociation curve analysis and gel electrophoresis. The efficiency of the qPCR reaction was calculated for each gene by creating a standard curve from twofold serial dilutions of cDNA. Amplification efficiencies were determined using the formula E ϭ 10ˆ(1/slope), with the slope of the linear curve of cycle threshold (C t) values plotted against the log dilution (29). Only primers with PCR efficiencies between 90 and 110% were used. The software package GenEx 5.2.1.3 (MultiD Analyses) was used for efficiency correction of the raw cycle threshold values, normalization to the reference genes, and calculation of quantities relative to the average C t value for each gene.
Statistical Analysis
Hormonal response profiles from the GHRH challenge were subjected to area under the curve (AUC) analysis using Sigma plot (version 11.0). AUC and gene expression data were checked for normality using the UNIVARIATE procedure of SAS (SAS Inst., Cary, NC). Where necessary, data were transformed using the TransReg procedure, by raising to the power of . Data were analyzed using mixed models methodology (PROC MIXED, SAS). Treatment and period as well as their interaction were included as the main effects, with block included as a random effect in the statistical model. Where no interactions were observed, the data were reanalyzed for main effects only. The Tukey critical difference test was performed to determine the existence of statistical differences between treatment mean values. Feed intake, weight, and live weight gain were analyzed by the same procedure (36) . For the hormonal response profile analysis, AUC for the three baseline growth hormone and IGF-1 plasma results were included in the statistical model as a covariate. Spearman partial correlation coefficients were calculated to determine associations among gene expression values for each gene.
RESULTS

Animal Performance
Differences in live weight gain, feed intake, and animal performance are outlined in detail by Keogh et al. (36) . In brief, RES animals had a lower feed intake during period 1 (P Ͻ 0.001); however, subsequently there was no difference in intake between groups in period 2 (P Ͼ 0.05). At the end of 125 days of differential feeding during period 1 as expected, the live weight was different between groups, with values of 442 and 603 kg observed for RES and ADLIB, respectively (P Ͻ 0.01). Following 55 days of ad libitum feeding for both groups in period 2, live weights were 594 and 678 kg for RES and ADLIB, respectively (P Ͻ 0.001). The difference in live weight between the two groups at the end of period 1 was 161 kg. This was reduced to 84 kg at the end of period 2. During period 1, live weight gain was 0.6 kg/day in RES animals and 1.9 kg/day in ADLIB animals. During period 2, RES grew at 2.5 kg/day, while their ADLIB counterparts grew at 1.4 kg/day (P Ͻ 0.001). RES animals displayed a lower feed efficiency coefficient (RES vs ADLIB: 4.87 vs. 9.98 kg weight gain/kg feed intake) compared with ADLIB animals during period 2 (P Ͻ 0.001). The growth curves for both RES and ADLIB animals are presented in Fig. 1 . Liver weight of RES animals at the end of period 1 was 4 kg lighter than that of their ADLIB contemporaries (P Ͻ 0.001), while there was no difference (P Ͼ 0.05) in liver weight between treatment groups following 55 days of re-alimentation at the end of period 2.
GHRH Challenge
The effect of feed restriction and re-alimentation on both growth hormone and IGF-1 responses to GHRH administration are presented in Table 2 . There was no effect of either treatment or period on the growth hormone response to GHRH administration (P Ͼ 0.05). However, a treatment ϫ period interaction (P Ͻ 0.05) was evident for IGF-1 response, which was lower in RES animals in period 1, and subsequently greater in these animals in period 2.
Gene Expression
The effect of treatment and period on the hepatic expression of genes of the somatotropic axis is presented in Table 3 . Treatment ϫ period interactions were identified for IGF1 (P Ͻ 0.001), IGFBP2 (P Ͻ 0.01) and GHR1A (P Ͻ 0.05). IGF1 and GHR1A mRNA expression were lower in period 1 in RES animals. During period 2, however, expression of GHR1A was greater in RES animals following re-alimentation. Additionally, there was no difference in IGF1 transcript abundance during this time. IGFBP2 mRNA expression was much greater for RES compared with ADLIB animals during feed restriction in period 1, with no difference observed during period 2. Expression of IGFBP1 mRNA was greater in RES animals across both periods (P Ͻ 0.001). There was an effect of period on transcript abundance for IGFBP6 that was greater for both RES and ADLIB in period 1 compared with period 2 (P Ͻ 0.001). GHRtot expression was lower in both treatment groups in period 1 compared with period 2 (P Ͻ 0.05). Nutritional treatment ϫ period interactions were observed for IGF1, IGFBP2, and GHR1A, and these are illustrated in Figs. 2, 3 , and 4, respectively. Feed restriction and subsequent re-alimentation did not affect (P Ͼ 0.05) the expression of SOCS3, JAK2, STAT5B, IGFBP3, IGFBP4, IGFBP5, or ALS. Correlation coefficients between transcript levels of genes of the somatotropic axis are presented for period 1 and period 2 in Tables 4 and 5 , respectively.
DISCUSSION
The signaling of the somatotropic axis has widely been shown to be affected by both dietary restriction and subsequent re-alimentation (30, 37, 77) . However, there is a dearth of information on the molecular control of these effects. Thus, the objective of the current study was to examine the responsiveness of the somatotropic axis to varying nutritional status in cattle, in an effort to better understand its potential role, if any, in the regulation of the compensatory growth phenomenon. We used two approaches; the first aimed at stimulating hypothalamic growth hormone and hepatic IGF-1 protein production through use of a GHRH challenge, and the second set out to examine transcript abundance of genes of the somatotropic axis in the liver, which is the primary site of systemic IGF-1 synthesis (58) to feed restriction followed by subsequent realimentation.
Somatotropic Axis Uncoupling
The endogenous postprandial growth hormone secretory pattern, resulting in hepatic IGF-1 synthesis, is centrally involved in the partitioning of nutrients to various physiological processes such as tissue growth and accretion of body reserves (27, 71) . However, during periods of feed restriction, the signaling of the somatotropic axis may become refractory to the effects of growth hormone leading to a reduction in the secretion of IGF-1 (2). The decline in the concentration of anabolic hormones such as IGF-1 may be an adaptive response during dietary restriction that ensures that cellular growth is minimized while limited nutrients are targeted for essential Not significant (NS) ϭ P Ͼ 0.05. T, treatment; P, period; GHRH, growth hormone releasing hormonel RES, restricted fed animals; ADLIB, ad libitum fed animals. cellular functions, including tissue maintenance and repair. Consistent with our findings (37) , previous studies by others (15, 30, 78) have also reported reduced systemic IGF-1 concentrations in cattle during feed restriction, followed by the restoration of normal concentrations upon subsequent re-alimentation. Indeed, some authors have identified an increase in plasma growth hormone concentrations and lower IGF-1 concentrations during a period of restricted feeding (12, 43) . This rise in growth hormone concentrations may be attributable to a requirement for lipolysis, as high blood growth hormone concentrations promote adipose tissue mobilization and increase blood nonesterified fatty acid concentrations (45) . This metabolic adaptation may be required for the preservation of metabolic homeostasis during dietary restriction (4, 11, 67) . Alternatively, the greater growth hormone concentrations reported during feed restriction may be a consequence of the negative feedback loop within the somatotropic axis (45, 59) .
The inherent pulsatility of pituitary growth hormone release is governed by alternating episodes of stimulation by GHRH and inhibition by somatostatin (1, 44, 52) . Although, as previously stated, alterations in growth hormone and IGF-1 concentrations have been observed during dietary restriction and compensatory growth, the capacity of the pituitary gland to respond to its precursor, GHRH, and to synthesize growth hormone under these conditions has not been examined. Unlike extrinsic growth hormone supplementation, GHRH administration modulates intrinsic regulatory systems and evokes a normal pulsatile pattern of growth hormone release (51) . Furthermore, the growth hormone response to GHRH administration indicates pituitary sensitivity to GHRH rather than a pituitary capacity to secrete growth hormone (20) . The lack of difference between treatment groups in growth hormone response to GHRH administration in the current study indicates that pituitary sensitivity to synthesize growth hormone is not altered by dietary restriction nor subsequent re-alimentation. Similar to our own results, Li et al. (43) observed no difference in growth hormone response to a GHRH challenge between restricted and ad libitum-fed animals. In the current study, evidence of uncoupling of the somatotropic axis was apparent through an overall lowered IGF-1 response to GHRH administration in RES animals in period 1, with no difference in growth hormone synthesis observed between treatment groups. Elsasser et al. (26) also noted a lower IGF-1 response in cattle on a low plane of nutrition, compared with their contemporaries on a high-plane of nutrition, which was sustained over a 24 h period of sampling. However, in that study, growth hormone and not GHRH was administered (26) . Systemic IGF-1 response to the GHRH challenge in the current study was consistent with data recorded in previous work from our group with these animals, where regular blood sampling at more extended periods was employed (37) . In addition to evidence for uncoupling of the somatotropic axis at the systemic level, an examination of hepatic somatotropic axis gene transcript abundance resulted in the same conclusion. This was particularly clear through the large number of negative correlation coefficients between genes at the end of period 1.
Although not measured in the current study, SIRT1 activity in the brain may potentially be responsible for overall uncoupling of the somatotropic axis (9, 19, 54, 60) as SIRT1 has been shown to regulate somatotropic signaling in response to dietary restriction (19) .
Hepatic IGF-1 Synthesis
The liver is the predominant site of systemic IGF-1 production (58) though local synthesis occurs across a range of tissues. Thus, given the outcome of our GHRH challenge, the liver was chosen as the target tissue for further investigation of nutritional effects on the somatotropic axis during restricted feeding and subsequent re-alimentation. Binding of growth hormone to its specific receptor (GHR) induces a conformational change in the structure of the receptor that leads to receptor dimerization and juxtaposition of the Janus kinase (JAK2) proteins and activation of signal transducer and activator of transcription 5b member (STAT5B). An intact JAK2-STAT5B signaling cascade is necessary for growth hormone stimulation of IGF1 gene expression and thus for normal body growth (70) . In the current study, we failed to record any evidence of an effect of plane of nutrition or indeed realimentation on expression of either JAK2 or STAT5B. Additionally, SOCS3, which is a negative regulator, induced by growth hormone, and which works to inhibit JAK2 function (75), was also not differentially expressed between treatments groups in either period. However, transcript abundance of GHR1A and IGF1 were both lower in RES animals at the end of dietary restriction in period 1.
As a prominent site of IGF-1 production, the number of receptor binding sites in the liver is crucial for signaling for IGF-1 synthesis. Growth hormone treatment of healthy animals with an intact somatotropic axis leads to upregulation of high-affinity hepatic GHRs, increased synthesis and plasma concentrations of IGF-1 and IGFBP-3 (11). However, following a reduction in dietary intake in cattle, the number of high-affinity hepatic GHRs declines, and, as a consequence, IGF-1 synthesis is reduced (11) . A similar response is observed in rats where a reduction in the number of hepatic GHRs (48) and in GHR binding capacity (47) is observed. Likewise, in the current study, mRNA transcript abundance of the liver-specific GHR GHR1A was lower in RES animals at the end of dietary restriction in period 1. Lowered expression of this GHR gene may be linked to the observed smaller liver size and volume in RES animals recorded at the end of period 1 (36) . Other evidence suggests that the reduction in growth hormone binding may be due to decreased GHR recycling and translocation from the intracellular pool to the cell surface (42, 52) .
Expression of GHR and IGF1 genes in hepatic tissues has previously been shown to be acutely responsive to nutritional status and physiological state (10, 38, 45, 57) . As previously stated, dietary restriction may lead to the production of SIRT1, which may modulate tissue sensitivity to insulin (9, 54, 60) . The effect of insulin on somatotropic axis signaling has previously been described in cultures of primary rat hepatocytes, where IGF1 expression was increased in response to insulin (8, 40, 56) . Additionally, in their work on somatotropic axis signaling during early lactation, Butler et al. (14) noted a sudden increase in IGF1 and hepatic GHR1A transcript abundance to a chronic elevation of plasma insulin in cows that had previously displayed uncoupling of the somatotropic axis. The stimulatory effect of insulin on liver GHRs is also observed in humans and other species (5, 7, 50) . Due to the planned lowered dietary intake of RES animals in the current study, these animals also had lowered concentrations of circulating insulin during the same time that expression of GHR1A and IGF1 was lower (37) . Reduced expression of these genes may be due to the lowered insulin levels and an altered sensitivity to insulin in the liver. The opposite effect of increased insulin during re-alimentation in the animals used in the current study (37) may have contributed to the greater expression of GHR1A at the end of period 2. In similar cases of lower systemic insulin concentrations, such as in insulin-dependent diabetes mellitus in rats and mice, studies have shown that growth hormone binding to the liver is reduced (3, 16) . In these studies, hepatic growth hormone binding was subsequently increased with insulin treatment (3), providing strong evidence that insulin positively regulates hepatic GHRs. Furthermore, Leung et al. (42) demonstrated that insulin increased the number of total and intracellular compartments of GHR and also stimulated receptor biosynthesis. In this work, Leung et al. (42) attributed the effect of insulin on GHRs to be due to insulin causing dissociation between surface and total GHRs, suggesting that it regulates the subcellular distribution of the receptors. Additionally, insulin is recognized as a positive modulator of HNF-4 (24, 41), a liver enriched transcription factor that can increase the expression of GHR1A (33) .
IGF Binding Proteins
The insulin-like growth factor binding proteins (IGFBPs) function as carrier proteins, transporting IGF-1 out of the systemic circulation and into the target tissues. IGFBPs also prolong the half-life of IGF-1 by protecting it from proteolytic degradation (76) . Six different binding proteins have been identified, and they have a critical role in the functioning of the somatotropic axis through regulation of IGF-1 and IGF-1-receptor interaction (23, 34) . At a tissue level, IGFBP can both inhibit and potentiate IGF-1 action by either prohibiting IGF-1 from binding with the IGF-1 receptor or by releasing IGF-1 to bind IGF-1 receptor, respectively (22) . In addition, IGFBPs may have IGF-independent effects on cell function (74) . Fasting or restricted feeding have been shown to affect the concentrations of circulating levels of IGFBPs, in particular IGFBP1 and 2 (6, 11, 66, 71, 72) . Greater expression and synthesis of these binding proteins can have an impact on the bioavailability and bioactivity of IGF-1, inhibiting the actions of IGF-1 (59) . In the present study, mRNA expression of both IGFBP2 and IGFBP1 was greater in RES animals during period 1. Greater expression of these genes during dietary restriction may have had an inhibitory role in preventing IGF-1 bioactivity and signaling. The inhibitory action of these binding proteins was also evidenced through the negative associations between both binding proteins and IGF1 and GHR1A.
The role of IGFBP1 and IGFBP2 in potentially inhibiting hepatic IGF-1 bioactivity or bioavailabilty and subsequent signaling in the periphery may be due to a requirement to induce a mechanism for the preferential utilization of mobilized substrates to maintain homeostasis rather than promote cell growth and proliferation during dietary restriction (61) . Both IGFBP1 and IGFBP2 have previously been implicated in regulating IGF-1 bioactivity as a method to maintain blood glucose concentrations and insulin sensitivity (46) . Furthermore, decreases in body fat mass and insulin concentrations have been associated with increases in IGFBP1 and IGFBP2 (49, 74) , implicating these two binding proteins as being sensitive to insulin in respect of IGF-1 synthesis (25, 59, 65) . Indeed, insulin has been described as being the principal regulator of IGFBP1 production (13) . Additionally, Wheatcroft and Kearney (74) postulated that IGFBP2 concentrations are metabolically regulated and may reflect long-term alterations in hepatic exposure to insulin, as systemic IGFBP2 levels are typically increased after a prolonged period of fasting (18) . As previously stated, due to the planned lowered dietary intake of RES animals in period 1, lower plasma insulin concentrations were observed in these animals in period 1 (37) . As a consequence of this, hepatic sensitivity to insulin may have been altered during dietary restriction in the animals used in the current study, allowing increased synthesis of inhibitory binding proteins such as IGFBP1 and 2, ultimately preventing the bioactivity of IGF-1. Most likely, an overall inhibition of IGF-1 production and signaling would have inhibited energy being partitioned to tissue growth when nutrients were not in abundant supply to the animal. 
Somatotropic Axis Contribution to Compensatory Growth
The role of the somatotropic axis in growth, in addition to the rise in the systemic concentrations of IGF-1 during realimentation and compensatory growth (15, 30, 37, 78) , suggests a role for the somatotropic axis in the regulation of compensatory growth. Li et al. (43) reported greater systemic concentrations of growth hormone following administration of GHRH during compensatory growth in re-alimentation. These authors suggest that a greater growth hormone concentration during re-alimentation was contributing to compensatory growth through its role in stimulating protein accretion and fat catabolism, thereby improving the utilization of ingested feed. A recoupling of the axis following re-alimentation was apparent in the current study from both the results of the GHRH and the hepatic gene expression profiles. Furthermore, initial negative associations between the inhibitory binding proteins and IGF1 during differential feeding were subsequently positive following 55 days of re-alimentation. As previously stated insulin can affect the correct signaling of the somatotropic axis. Indeed the recoupling of the somatotropic axis observed in the current study coincided with greater insulin concentrations in these animals during re-alimentation and compensatory growth (37) , evidencing the role of insulin in relation to signaling of the somatotropic axis. Indeed, recoupling of the axis in both humans and cattle has been attributed to an increase in insulin concentrations alone (14, 42) . Greater insulin concentrations may have affected Sp1, a transcription factor that has the capacity to bind to regions of the IGF-1 gene and can contribute to IGF1 expression (55, 79) . However, although these results indicate recoupling and resumption of normal functionality of the somatotropic axis during compensatory growth, it is not apparent from the results of the current study that this signaling axis is a major contributor to the expression of compensatory growth in cattle. This was clear from the lack of greater expression of IGF1 gene expression at day 55 of re-alimentation and also from the only marginally greater IGF-1 response to systemic GHRH challenge. However, although the results of this study do not establish a role for greater systemic IGF-1 concentrations during early re-alimentation in compensatory growth, the role of the somatotropic axis signaling pathway in growth of peripheral tissues such as skeletal muscle remains to be elucidated.
Conclusions
Dietary restriction in the cattle in the current study caused uncoupling of the somatotropic axis, which was evident at both the systemic and the hepatic gene expression level; however, pituitary sensitivity was not affected by dietary restriction. These effects on the somatotropic axis may have been due, primarily, to the lowered systemic insulin concentrations as a consequence of dietary restriction. A reduction in insulin concentrations may have inhibited the expression of hepatic GHRs. Furthermore, the greater expression of IGF-1 inhibitory binding proteins 1 and 2 may have been due to reduced insulin concentrations also. The overall uncoupling of the axis during dietary restriction may reflect a requirement to maintain homeostasis rather than to promote cell growth and proliferation in these animals. Re-alimentation caused recoupling of the somatotropic axis, which may be attributed to the greater insulin concentrations associated with the greater feed intake in these animals. However, although recoupling of the axis was apparent, it is not clear from the results of this study that the somatotropic axis per se contributes largely to controlling the extent of compensatory growth, in the medium to longer term.
